STAT3 becomes inappropriately and constitutively activated in a high percentage of solid malignancies including melanoma, multiple myeloma, and cancers of the breast, ovary, prostate, head and neck, and pancreas [25]. The gene discussed is STAT3; the disease is plasma cell myeloma.